Autism and Emotion: A Narrative Review

Sagayaraj Kanagaraj; S. Devishrree; J. Swetha; B. Krishna Priya; Srivarshini Sankar; Jincy Cherian; C.N. Ram Gopal; S. Karthikeyan

doi:10.1055/s-0041-1736277

Journal of Health and Allied Sciences NU, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2022; 12(02): 196-207
DOI: 10.1055/s-0041-1736277

Review Article

Autism and Emotion: A Narrative Review

Sagayaraj Kanagaraj

¹Department of Counseling Psychology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamil Nadu, India

,

S. Devishrree

²Department of Clinical Psychology, National Institute for Empowerment of Persons with Multiple Disabilities (Divyangjan), East Coast Road, Chennai, Tamil Nadu, India

,

J. Swetha

³Department of Rehabilitation Psychology, National Institute for Empowerment of Persons with Intellectual Disabilities (Divyangjan), Manovikas Nagar, Secunderabad, Telangana, India

,

B. Krishna Priya

⁴Department of Counseling Psychology, University of Madras, Chennai, Tamil Nadu, India

,

Srivarshini Sankar

⁵School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India

,

Jincy Cherian

⁶Department of Psychology, Dayalbagh Educational Institute, Agra, Uttar Pradesh, India

,

C.N. Ram Gopal

¹Department of Counseling Psychology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamil Nadu, India

,

S. Karthikeyan

²Department of Clinical Psychology, National Institute for Empowerment of Persons with Multiple Disabilities (Divyangjan), East Coast Road, Chennai, Tamil Nadu, India

› Institutsangaben

Abstract

Autism spectrum disorder (ASD) includes a variety of childhood-onset and lifelong neurodevelopmental condition with an enduring impact on multiple domains of functioning characterized by persistent deficits in social communication, restricted and repetitive behavior interest, and activities. They often find it hard to recognize and control emotions but their emotional expression can be improved by various intervention techniques that in turn can help them understand and respond more appropriately to other people. Problems in the area on emotional reciprocity among individual with ASD involve recognizing, understanding, expressing, and regulating emotions. Their ability in emotional reciprocity is often improved with a comprehensive treatment approach, especially by focused emotional enhancement intervention. In this review, we followed the standard IMRAD (Introduction, Methods, Results, and Discussion) structure to critically examine the condition of autism and its relation with genetic mechanism, and how theories of emotion and theory of mind associated with persons with ASD, some of the widely used assessment tools and future research direction in the emotional development of individuals diagnosed with ASD by using the narrative review method. Records collected through research databases such as Scopus, PubMed, Web of Science, Medline, EBSCO and published books with ISBN (International Standard Book Number), and published test manuals were evaluated in-depth and summarized based on the subtopic of the proposed title. A critical theoretical analysis of the genetic mechanism of emotions, theories of emotions, and theory of mind was explained in connection with ASD.

Keywords

autism - emotion - theories of emotion - theory of mind

Volltext

Referenzen

References
1 World Health Organization. International classification of diseases for mortality and morbidity statistics, 11 ^th Revi. Accessed August 10, 202 at: https://icd.who.int/browse11/l-m/en
2 Kopetz PB, Endowed ED. Autism worldwide: prevalence, perceptions, acceptance, action. J Soc Sci 2012; 8: 196-201
3 Matson JL, Worley JA, Fodstad JC. et al. A multinational study examining the cross cultural differences in reported symptoms of autism spectrum disorders: Israel, South Korea, the United Kingdom, and the United States of America. Res in Aut Spec Dis 2011; 5: 1598-1604
4 Rice CE, Rosanoff M, Dawson G. et al. Evaluating changes in the prevalence of the autism spectrum disorders. Public Health Rev 2012; 34 (02) 1-22
5 Christensen DL, Baio J, Van Naarden Braun K. et al; Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). Prevalence and characteristics of autism spectrum disorder among children aged 8 years–autism and developmental disabilities monitoring network, 11 Sites, United States, 2012. MMWR Surveill Summ 2016; 65 (03) 1-23
6 Mannion A, Leader G. Comorbidity in autism spectrum disorder: a literature review. Res in Aut Spec Dis 2013; 7: 1595-1616
7 Doshi-Velez F, Ge Y, Kohane I. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics 2014; 133 (01) e54-e63
8 Romero M, Aguilar JM, Del-Rey-Mejías Á. et al. Psychiatric comorbidities in autism spectrum disorder: A comparative study between DSM-IV-TR and DSM-5 diagnosis. Int J Clin Health Psychol 2016; 16 (03) 266-275
9 Corsello CM. Early intervention in autism. Infants Young Child 2005; 18: 74-85
10 Kasari C, Patterson S. Interventions addressing social impairment in autism. Curr Psychiatry Rep 2012; 14 (06) 713-725
11 DeFilippis M, Wagner KD. Treatment of autism spectrum disorder in children and adolescents. Psychopharmacol Bull 2016; 46 (02) 18-41
12 Pasco G. The value of early intervention for children with autism. Pediatr and Chil Heal 2018; 28: 364-367
13 Sagayaraj K, Gopal CNR, Karthikeyan S. The efficacy of technology and non-technology based intervention for children with autism spectrum disorder: a meta-analysis. Inter J Inno Sci and Res Tech 2020; 5: 863-868
14 Aman MG, Novotny S, Samango-Sprouse C. et al. Outcome measures for clinical drug trials in autism. CNS Spectr 2004; 9 (01) 36-47
15 Posey DJ, Stigler KA, Erickson CA, McDougle CJ. Antipsychotics in the treatment of autism. J Clin Invest 2008; 118 (01) 6-14
16 Hampson DR, Gholizadeh S, Pacey LKK. Pathways to drug development for autism spectrum disorders. Clin Pharmacol Ther 2012; 91 (02) 189-200
17 Ghosh A, Michalon A, Lindemann L, Fontoura P, Santarelli L. Drug discovery for autism spectrum disorder: challenges and opportunities. Nat Rev Drug Discov 2013; 12 (10) 777-790
18 World Health Organization. News room, Fact sheet, Detail – Autism Spectrum Disorder. 2021 Jun 1. (Cited 2021 Jul 1); Accessed August 09, 2021 from https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders
19 Sun X, Allison C. A review of the prevalence of autism spectrum disorder in Asia. Res Autism Spectr Disord 2010; 4 (02) 156-167
20 Hossain MD, Ahmed HU, Jalal Uddin MM. et al. Autism spectrum disorders (ASD) in South Asia: a systematic review. BMC Psychiatry 2017; 17 (01) 281
21 Arora NK, Nair MKC, Gulati S. et al. Neurodevelopmental disorders in children aged 2-9 years: population-based burden estimates across five regions in India. PLoS Med 2018; 15 (07) e1002615
22 Rylaarsdam L, Guemez-Gamboa A. Genetic causes and modifiers of autism spectrum disorder. Front Cell Neurosci 2019; 13: 385
23 Hori K, Nagai T, Shan W. et al. Heterozygous disruption of autism susceptibility candidate 2 causes impaired emotional control and cognitive memory. PLoS One 2015; 10 (12) e0145979
24 Bevilacqua L, Goldman D. Genetics of emotion. Trends Cogn Sci 2011; 15 (09) 401-408
25 Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Männistö PT. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 2007; 27 (38) 10196-10209
26 Scanlon PD, Raymond FA, Weinshilboum RM. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science 1979; 203 (4375): 63-65
27 Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 2003; 13 (01) 33-41
28 Dapretto M, Davies MS, Pfeifer JH. et al. Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 2006; 9 (01) 28-30
29 Pessoa L. Emergent processes in cognitive-emotional interactions. Dialogues Clin Neurosci 2010; 12 (04) 433-448
30 Ursini G, Bollati V, Fazio L. et al. Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci 2011; 31 (18) 6692-6698
31 Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006; 7 (10) 818-827
32 Rzhetsky A, Wajngurt D, Park N, Zheng T. Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci U S A 2007; 104 (28) 11694-11699
33 Lesch KP, Bengel D, Heils A. et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274 (5292): 1527-1531
34 Piven J, Chase GA, Landa R. et al. Psychiatric disorders in the parents of autistic individuals. J Am Acad Child Adolesc Psychiatry 1991; 30 (03) 471-478
35 Tordjman S, Anderson GM, McBride PA. et al. Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry 1997; 38 (06) 705-715
36 Hu XZ, Lipsky RH, Zhu G. et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006; 78 (05) 815-826
37 Hariri AR, Mattay VS, Tessitore A. et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297 (5580): 400-403
38 Heinz A, Braus DF, Smolka MN. et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8 (01) 20-21
39 Pezawas L, Meyer-Lindenberg A, Drabant EM. et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8 (06) 828-834
40 Caspi A, Sugden K, Moffitt TE. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301 (5631): 386-389
41 Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, Ohman A. Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychol Sci 2009; 20 (02) 198-206
42 Lee HJ, Macbeth AH, Pagani JH, Young III WS. Oxytocin: the great facilitator of life. Prog Neurobiol 2009; 88 (02) 127-151
43 Kirsch P. Oxytocin in the socioemotional brain: implications for psychiatric disorders. Dialogues Clin Neurosci 2015; 17 (04) 463-476
44 Windle RJ, Shanks N, Lightman SL, Ingram CD. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997; 138 (07) 2829-2834
45 Kirsch P, Esslinger C, Chen Q. et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 2005; 25 (49) 11489-11493
46 Koch SB, van Zuiden M, Nawijn L, Frijling JL, Veltman DJ, Olff M. Intranasal oxytocin normalizes amygdala functional connectivity in posttraumatic stress disorder. Neuropsychopharmacology 2016; 41 (08) 2041-2051
47 Auyeung B, Lombardo MV, Heinrichs M. et al. Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism. Transl Psychiatry 2015; 5: e507
48 Lucht MJ, Barnow S, Sonnenfeld C. et al. Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33 (05) 860-866
49 Yamasue H, Domes G. Oxytocin and autism spectrum disorders. Curr Top Behav Neurosci 2018; 35: 449-465
50 LoParo D, Waldman ID. The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis. Mol Psychiatry 2015; 20 (05) 640-646
51 Yamasue H. Function and structure in social brain regions can link oxytocin-receptor genes with autistic social behavior. Brain Dev 2013; 35 (02) 111-118
52 Ahima RS, Harlan RE. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 1990; 39 (03) 579-604
53 Kovács KJ, Földes A, Sawchenko PE. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J Neurosci 2000; 20 (10) 3843-3852
54 Criado-Marrero M, Rein T, Binder EB, Porter JT, Koren III J, Blair LJ. Hsp90 and FKBP51: complex regulators of psychiatric diseases. Philos Trans R Soc Lond B Biol Sci 2018; 373 (1738): 20160532
55 Binder EB, Salyakina D, Lichtner P. et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36 (12) 1319-1325
56 Willour VL, Chen H, Toolan J. et al; Bipolar Disorder Phenome Group, NIMH Genetics Initiative Bipolar Disorder Consortium. Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry 2009; 14 (03) 261-268
57 Ising M, Depping AM, Siebertz A. et al. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 2008; 28 (02) 389-398
58 Ressler KJ, Mercer KB, Bradley B. et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011; 470 (7335): 492-497
59 Falluel-Morel A, Tascau LI, Sokolowski K, Brabet P, DiCicco-Bloom E. Granule cell survival is deficient in PAC1-/- mutant cerebellum. J Mol Neurosci 2008; 36 (1-3): 38-44
60 Ghzili H, Grumolato L, Thouënnon E. et al. Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol 2008; 29 (01) 128-141
61 Harmar T, Lutz E. Multiple receptors for PACAP and VIP. Trends Pharmacol Sci 1994; 15 (04) 97-99
62 Hashimoto H, Shintani N, Baba A. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann N Y Acad Sci 2006; 1070: 75-89
63 Mounien L, Do Rego JC, Bizet P. et al. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology 2009; 34 (02) 424-435
64 Stroth N, Holighaus Y, Ait-Ali D, Eiden LE. PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Ann N Y Acad Sci 2011; 1220: 49-59
65 Dias BG, Ressler KJ. PACAP and the PAC1 receptor in post-traumatic stress disorder. Neuropsychopharmacology 2013; 38 (01) 245-246
66 Mercer KB, Dias B, Shafer D. et al. Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1. Transl Psychiatry 2016; 6 (12) e978
67 Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992; 15: 353-375
68 Diener SJ, Nees F, Wessa M. et al. Reduced amygdala responsivity during conditioning to trauma-related stimuli in posttraumatic stress disorder. Psychophysiology 2016; 53 (10) 1460-1471
69 Giustino TF, Maren S. The role of the medial prefrontal cortex in the conditioning and extinction of fear. Front Behav Neurosci 2015; 9: 298
70 Shin LM, Rauch SL, Pitman RK. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 2006; 1071: 67-79
71 Goodrich M, Armour AC, Panchapakesan K. et al. PAC1R genotype to phenotype correlations in autism spectrum disorder. Autism Res 2019; 12 (02) 200-211
72 Baron-Cohen S. Do people with autism understand what causes emotion?. Child Dev 1991; 62 (02) 385-395
73 Losh M, Capps L. Understanding of emotional experience in autism: insights from the personal accounts of high-functioning children with autism. Dev Psychol 2006; 42 (05) 809-818
74 Gaigg SB. The interplay between emotion and cognition in autism spectrum disorder: implications for developmental theory. Front Integr Nuerosci 2012; 6: 113
75 Fitzpatrick P, Frazier JA, Cochran D, Mitchell T, Coleman C, Schmidt RC. Relationship between theory of mind, emotion recognition, and social synchrony in adolescents with and without autism. Front Psychol 2018; 9: 1337
76 James W. What is an emotion?. Mind 1884; 9: 188-205
77 Lange CG. The Mechanism of the Emotions. Boston: Houghton Mifflin; 1912: 672-684
78 Clarke C. Autism spectrum disorder and amplified pain. Case Reports in Psyc 2015; 2015: 930874
79 Gu X, Zhou TJ, Anagnostou E. et al. Heightened brain response to pain anticipation in high-functioning adults with autism spectrum disorder. Eur J Neurosci 2018; 47 (06) 592-601
80 Vaughan S, McGlone F, Poole H, Moore DJ. A quantitative sensory testing approach to pain in autism spectrum disorders. J Autism Dev Disord 2020; 50 (05) 1607-1620
81 Friedman BH. Feelings and the body: the Jamesian perspective on autonomic specificity of emotion. Biol Psychol 2010; 84 (03) 383-393
82 Newman EB, Perkins FT, Wheeler RH. Cannon's theory of emotion: a critique. Psychol Rev 1930; 37: 305-326
83 Poquérusse J, Pastore L, Dellantonio S, Esposito G. Alexithymia and autism spectrum disorder: a complex relationship. Front Psychol 2018; 9: 1196
84 Sifneos PE. The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 1973; 22 (02) 255-262
85 Hadjikhani N, Zürcher NR, Rogier O. et al. Emotional contagion for pain is intact in autism spectrum disorders. Transl Psychiatry 2014; 4: e343
86 Meng J, Li Z, Shen L. Responses to others' pain in adults with autistic traits: The influence of gender and stimuli modality. PLoS One 2017; 12 (03) e0174109
87 Schachter S, Singer JE. Cognitive, social, and physiological determinants of emotional state. Psychol Rev 1962; 69: 379-399
88 Tager-Flusberg H. A psychological approach to understanding the social and language impairments in autism. Int Rev Psychiatry 1999; 11 (04) 325-334
89 Macari S, DiNicola L, Kane-Grade F. et al. Emotional expressivity in toddlers with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2018; 57 (11) 828-836.e2
90 Lazarus RS. Emotion and Adaptation. New York: Oxford University Press; 1991
91 Green L, Fein D, Joy S. et al. Cognitive functioning in autism. In: Schopler E, Mesibov GB. eds. Learning and Cognition in Autism. Current Issues in Autism. Boston: Springer; 1995: 13-31
92 Barrett LF, Mesquita B, Ochsner KN, Gross JJ. The experience of emotion. Annu Rev Psychol 2007; 58: 373-403
93 Darwin CR. The Expression of the Emotions in Man and Animals. London: John Murray; 1872
94 Perkins T, Stokes M, McGillivray J, Bittar R. Mirror neuron dysfunction in autism spectrum disorders. J Clin Neurosci 2010; 17 (10) 1239-1243
95 Premack D, Woodruff G. Does the chimpanzee have a theory of mind?. Behav Brain Sci 1978; 1: 515-526
96 Baron-Cohen S. The theory of mind deficit in autism: how specific is it?. British J Dev Psy 1991; 9: 301-314
97 Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a “theory of mind”?. Cognition 1985; 21 (01) 37-46
98 Tine M, Lucariello J. Unique theory of mind differentiation in children with autism and Asperger syndrome. Autism Res Treat 2012; 2012: 505393
99 Hoogenhout M, Malcolm-Smith S. Theory of mind predicts severity level in autism. Autism 2017; 21 (02) 242-252
100 Chauhan A, Sahu JK, Jaiswal N. et al. Prevalence of autism spectrum disorder in Indian children: a systematic review and meta-analysis. Neurol India 2019; 67 (01) 100-104
101 Malhotra S, Vikas A. Pervasive developmental disorders: Indian scene. J Indian Association of Child Adolescent Mental Health 2005; 1: 5
102 Rudra A, Banerjee S, Singhal N, Barua M, Mukerji S, Chakrabarti B. Translation and usability of autism screening and diagnostic tools for autism spectrum conditions in India. Autism Res 2014; 7 (05) 598-607
103 Lord C, Rutter M, Pamela C. et al. ADOS: Autism Diagnostic Observation Schedule. Boston, MA: Hogrefe; 2008
104 Rutter M, Le Couteur A, Lord C.. ADI-R: Autism Diagnostic Interview-Revised (ADI-R). Los Angeles, CA: Western Psychological Services; 2003
105 Lord C, Rutter M, DiLavore P. et al. Autism Diagnostic Observation Schedule. 2nd edition (ADOS-2). Los Angeles, CA: Western Psychological Corporation; 2012
106 Le Couteur A, Rutter M, Lord C. et al. Autism diagnostic interview: a standardized investigator-based instrument. J Autism Dev Disord 1989; 19 (03) 363-387
107 Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 1980; 10 (01) 91-103
108 Schopler E, Van Bourgondien ME, Wellman GJ. et al. CARS-2: Childhood Autism Rating Scale. Second Edition. Los Angeles, CA: West Psy Ser; 2010
109 Gilliam JE. GARS-3: Gilliam Autism Rating Scale. Third edition. Austin, TX: PRO-ED; 2014
110 Rutter M, Bailry A, Lord C. The Social Communication Questionnaire. Los Angeles: West Psy Ser; 2003
111 Juneja M, Mishra D, Russell PS. et al; INCLEN Study Group. INCLEN Diagnostic Tool for Autism Spectrum Disorder (INDT-ASD): development and validation. Indian Pediatr 2014; 51 (05) 359-365
112 National Institute for Mentally Handicapped, Ministry of Social Justice and Empowerment, Department of Empowerment of Persons with Disabilities. (Divyangjan) Government of India. Indian Scale for Assessment of Autism (ISAA). Test Manual; New Delhi: 2009
113 de Bildt A, Sytema S, Ketelaars C. et al. Interrelationship between Autism Diagnostic Observation Schedule-Generic (ADOS-G), Autism Diagnostic Interview-Revised (ADI-R), and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) classification in children and adolescents with mental retardation. J Autism Dev Disord 2004; 34 (02) 129-137
114 Wong CM, Singhal S. INDT-ASD: an autism diagnostic tool for Indian children. Developmental pediatrician's perspective. Indian Pediatr 2014; 51 (05) 355-356
115 Raina SK, Kashyap V, Bhardwaj AK, Kumar D, Chander V. Prevalence of autism spectrum disorders among children (1-10 years of age) - findings of a mid-term report from Northwest India. J Postgrad Med 2015; 61 (04) 243-246